Loading company…
Shanghai Changde Medical Technology develops devices for peripheral vascular interventions, including catheters and thrombus removal equipment.
Shanghai Changde Medical Technology develops devices for peripheral vascular interventions, including drug balloons, catheters, stents, and thrombus removal equipment. Its products include the EF-Rhine peripheral vascular constraint balloon dilatation catheter, and it works with Control Medical on its mechanical thrombus clearance system. Established in 2021 and based in Shanghai, China, it raised Series A+ funding in April 2025 led by Shanghai Healthcare Capital, with Xingzheng Capital participating. The funding is intended for clinical trials, registrations, and market expansion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in